ITMCTR2200005811
Not yet recruiting
未知
Cohort Study on Treatment of Cardiovascular Diseases with Traditional Chinese Medicine
Tianjin University of Traditional Chinese Medicine0 sitesTBD
ConditionsCardiovascular Diseases
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Cardiovascular Diseases
- Sponsor
- Tianjin University of Traditional Chinese Medicine
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •All patients admitted to the Department of Cardiovascular Medicine at The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, The Second Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin Chest Hospital, Tianjin Hospital of ITCWM Nankai Hospital and Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital were considered for inclusion in this study, and all Western medical diagnoses were identified and classified according to the International Classification of Diseases, 11th Revision (ICD\-11\).
Exclusion Criteria
- •No exclusion criteria.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
A Prospective Cohort Study of Cardiovascular Diseases in a Cardiovascular Hospital in an Urban Area of JapaCardiovascular DiseasesJPRN-UMIN000008598The Cardiovascular Institute30,000
Not yet recruiting
Phase 2
A cohort study on the treatment of coronary heart disease with the method of promoting qi and blood circulation (retrospective)Coronary heart diseaseITMCTR2023000063Xiyuan Hospital, China Academy of Chinese Medical Sciences
Not yet recruiting
Not Applicable
A cohort study on the treatment of coronary heart disease with the method of promoting qi and blood circulation (prospective)Coronary heart diseaseITMCTR2023000064Xiyuan Hospital, China Academy of Chinese Medical Sciences
Completed
Not Applicable
Concurrent Treatment of Cardiovascular Disease in Peritoneal Dialysis (PD) patients. Multi-center Randomized Clinical Study with Aldosterone blockade (spironolactone) and Angiotensin Receptor Blocker (ARB) or Angiotensin-Converting-Enzyme Inhibitor (ACEI).End-Stage Renal Disease (ESRD) and Cardio-Vascular Disease (CVD)JPRN-UMIN000000492agoya University160
Recruiting
Not Applicable
Survey of patients with cardiovascular diseases on general nutritional knowledgeCardiovascular diseasesDRKS00032227Medical Park St. Hubertus, Bad Wiessee136